Rhea-AI Summary
Abiomed, Inc. (NASDAQ: ABMD) will release its financial results for Q2 FY2021 on October 29, 2020, at 8:00 a.m. ET. The conference call, hosted by CEO Michael R. Minogue and CFO Todd Trapp, will provide insights into the company's performance. A replay will be available from 11:00 a.m. ET on October 29 to 10:00 a.m. ET on November 5, 2020. Abiomed specializes in circulatory support medical devices aimed at enhancing heart function.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags